FBXO34 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.857600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.464000E-01
Normal-vs-Stage2
4.842400E-01
Normal-vs-Stage3
5.541600E-01
Normal-vs-Stage4
1.456760E-01
Stage1-vs-Stage2
1.810170E-01
Stage1-vs-Stage3
6.983000E-01
Stage1-vs-Stage4
4.216200E-02
Stage2-vs-Stage3
1.378580E-01
Stage2-vs-Stage4
6.380000E-02
Stage3-vs-Stage4
7.180500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.092200E-01
Normal-vs-AfricanAmerican
7.476800E-01
Normal-vs-Asian
5.651800E-01
Caucasian-vs-AfricanAmerican
7.770400E-01
Caucasian-vs-Asian
6.610000E-01
AfricanAmerican-vs-Asian
6.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.802000E-01
Normal-vs-Female
6.126400E-01
Male-vs-Female
7.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.444000E-01
Normal-vs-Age(41-60Yrs)
3.237200E-01
Normal-vs-Age(61-80Yrs)
7.332600E-01
Normal-vs-Age(81-100Yrs)
9.735200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.780000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.087800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.343800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.224490E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.334200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.339400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.146400E-01
Normal-vs-Daily Drinker
7.425000E-01
Normal-vs-Weekly Drinker
9.686600E-01
Normal-vs-Occasional Drinker
3.878400E-01
Normal-vs-Social Drinker
5.368800E-01
Non Drinker-vs-Daily Drinker
8.747400E-01
Non Drinker-vs-Weekly Drinker
4.830800E-01
Non Drinker-vs-Occasional Drinker
2.289400E-01
Non Drinker-vs-Social Drinker
9.542400E-01
Daily Drinker-vs-Weekly Drinker
5.099600E-01
Daily Drinker-vs-Occasional Drinker
4.152200E-01
Daily Drinker-vs-Social Drinker
9.078800E-01
Weekly Drinker-vs-Occasional Drinker
1.405380E-01
Weekly Drinker-vs-Social Drinker
4.759200E-01
Occasional Drinker-vs-Social Drinker
2.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.282770E-01
Normal-vs-Grade 2
2.182300E-02
Normal-vs-Grade 3
9.360600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.677100E-03
Grade 1-vs-Grade 3
6.180900E-03
Grade 1-vs-Grade 4
1.282770E-01
Grade 2-vs-Grade 3
8.307600E-01
Grade 2-vs-Grade 4
2.182300E-02
Grade 3-vs-Grade 4
9.360600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.075000E-01
Normal-vs-NonDiabetic
5.812000E-01
Diabetic-vs-NonDiabetic
3.530200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.315000E-01
Normal-vs-NoPancreatitis
6.486800E-01
Pancreatitis-vs-NoPancreatitis
4.785800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.967400E-01
Normal-vs-N1
4.784400E-01
N0-vs-N1
1.136180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.538200E-01
Normal-vs-TP53-NonMutant
8.374400E-01
TP53-Mutant-vs-TP53-NonMutant
1.342010E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
